S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

SXTC China SXT Pharmaceuticals Inc

0.52

0.0323 (6.62%)

04 Jan 2025 - Closed

Delayed by 15 minutes

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

China SXT Pharmaceuticals (NASDAQ:SXTC)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more China SXT Pharmaceuticals Charts.

China SXT Pharmaceuticals (NASDAQ:SXTC)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more China SXT Pharmaceuticals Charts.

China SXT Pharmaceuticals Inc News

Form EFFECT - Notice of Effectiveness
Tuesday 5 November 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Saturday 26 October 2024 (2 months ago) • Edgar (US Regulatory)

Form F-3 - Registration statement by foreign private issuers
Wednesday 23 October 2024 (2 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Wednesday 16 October 2024 (3 months ago) • Edgar (US Regulatory)

China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency
Tuesday 8 October 2024 (3 months ago) • GlobeNewswire Inc.

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Wednesday 14 August 2024 (5 months ago) • Edgar (US Regulatory)

Form NT 20-F - Notification of inability to timely file Form 20-F
Thursday 1 August 2024 (5 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Wednesday 15 May 2024 (8 months ago) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Friday 12 January 2024 (12 months ago) • Edgar (US Regulatory)

More China SXT Pharmaceuticals Inc News Articles

National Australia Bank

Australia And New Zealan...

Sterling vs AUD

Commonwealth Bank Of Aus...

Newcrest Mining

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions